💨 Abstract

A recent study published in Cell Press reveals the significance of gamma-delta T cells in 33 different types of cancer, potentially making them useful as clinical biomarkers and therapeutic targets. This research, led by experts at Moffitt Cancer Center, analyzed gamma-delta T-cell receptor landscapes across 11,000 tumors using a novel computational algorithm.

Courtesy: theprint.in